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Incursions of new pathogenic viruses into humans
from animal reservoirs are occurring with alarming
frequency. The molecular underpinnings of immune
recognition, host responses, and pathogenesis in
this setting are poorly understood. We studied
pandemic influenza viruses to determine the mech-
anism by which increasing glycosylation during
evolution of surface proteins facilitates diminished
pathogenicity in adapted viruses. ER stress during
infection with poorly glycosylated pandemic strains
activated the unfolded protein response, leading to
inflammation, acute lung injury, and mortality. Sea-
sonal strains or viruses engineered to mimic adapted
viruses displaying excess glycans on the hemagglu-
tinin did not cause ER stress, allowing preservation
of the lungs and survival. We propose that ER stress
resulting from recognition of non-adapted viruses is
utilized to discriminate ‘‘non-self’’ at the level of pro-
tein processing and to activate immune responses,
with unintended consequences on pathogenesis.
Understanding this mechanism should improve stra-
tegies for treating acute lung injury from zoonotic
viral infections.INTRODUCTION
Societal changes, characterized by increased global traffic and a
breakdown in historical barriers to transit, have fundamentally
altered the natural history of viral infections, allowing sporadic
spread of infectious agents around the world within days.
Some of these outbreaks, exemplified by the severe acute respi-
ratory syndrome virus (SARS), highly pathogenic avian influenza
viruses (e.g., H5N1 subtype strains), and the Middle Eastern
respiratory syndrome coronavirus (MERS-CoV), result in high
morbidity and mortality and cause significant disruptions to so-Ceciety due to public fears of infection and the necessary govern-
mental responses (Enserink, 2014; van den Brand et al., 2014).
Interestingly, not all viral infections result in pathology. Many
viruses have adapted well enough to humans that they can
undergo robust replication cycles with little to no evidence of im-
mune recognition and response or at least no immune responses
that are damaging to the host. As an example, Sendai virus, a
close relative of the human respiratory pathogen parainfluenza
virus-1, infects humans in an analogous manner to related
respiratory viruses but causes no disease (Faı´sca and Des-
mecht, 2007). The interplay of virus and host factors that dictate
pathology in these various infection scenarios is very poorly
understood.
Influenza A viruses (IAVs) represent an interesting and relevant
model to study this phenomenon. All IAVs are zoonoses,
emerging periodically from animal reservoirs and sometimes es-
tablishing endemicity in humans (Webster et al., 1992). When
these initial incursions spread worldwide, they are termed pan-
demics and are often characterized by severe morbidity and
highmortality as exemplified by the 1918H1N1 pandemic, which
killed more than 50 million persons. However, over several de-
cades of circulation, these strains adapt and generally become
less pathogenic. The changes to the virus that result in reduced
morbidity and the corresponding host pathways and processes
that are involved are only now being explicated. Although several
mechanisms are likely responsible, the tendency of seasonal
influenza strains to gain excess glycosylation on the surface pro-
tein hemagglutinin (HA) has been identified as a key factor (El
Moussi et al., 2014; Kim and Park, 2012; Medina et al., 2013;
Sun et al., 2013; Vigerust et al., 2007; Zhang et al., 2013). Mech-
anistically, gain of glycosylation sites on the HA globular head
has been linked to increased collagenous lectin (collectin) bind-
ing, resulting in virus neutralization (Tate et al., 2014; Vigerust
et al., 2007). Physical alteration of HA-receptor-binding sites,
thereby affecting receptor binding specificity and avidity and
potentially altering virus tropism (Jayaraman et al., 2012; Wang
et al., 2009), has also been studied. However, the observation
of differential inflammatory potential based on glycosylation
differences with downstream effects on pathogenesis has not
been explored.ll Reports 11, 1591–1603, June 16, 2015 ª2015 The Authors 1591
The HA protein, a 200-kDa homotrimer with an ectodomain
composed of a globular head and a stalk region (Wilson et al.,
1981) mediates attachment of the viral particle to the host cell
and escape from the endosome (Luo, 2012). Newly produced
HA is sorted into the protein secretory pathway through translo-
cation into the ER. During transport to the plasmamembrane, the
HA undergoes posttranslational modifications in the ER and
Golgi apparatus, where glycans are added to specific sites for
N-linked glycosylation. Some of these glycans, primarily in the
stalk region, are needed for proper protein folding and transport
(Daniels et al., 2003; Roberts et al., 1993). Others, on the globular
head, have no known function other than a proposed role in facil-
itation of immune escape from antibodies (Job et al., 2013; Tate
et al., 2014). In general, glycosylation has important roles in pro-
tein folding and quality control with the ER integrating protein
quality control mechanisms, such as cellular responses to the
accumulation of non-native or misfolded proteins (the ER stress
or unfolded protein response [UPR]) and their potential elimina-
tion (Roth et al., 2010). Alterations and/or disturbances in protein
glycosylation have been connected to human disease (Gre-
gersen et al., 2006; Roth et al., 2010).
Because previous studies have linked HA glycosylation to IAV
pathogenicity, we wanted to further explore the interplay be-
tween the HA protein and host pathways to better understand
fundamental relationships in virus recognition, induction of im-
mune responses, and subsequent pathology. Our findings
revealed a mechanism for self/non-self-discrimination by
which poorly glycosylated virus proteins, such as those from
pandemic IAV strains, are recognized as non-self, mediating vi-
rus recognition, airway inflammatory responses, and pathoge-
nicity. Viruses that have adapted to humans through selection
for excess glycosylation sites or viruses artificially constructed
to carry excess glycans are not recognized by this innate
sensing mechanism and are able to replicate without pathologic
consequences.
RESULTS
The Pandemic HA Drives Pathogenesis
To understand the differences in the pathobiology of pandemic
and seasonal IAVs, we investigated immune responses and pa-
thology using relevant, naturally occurring strains. Infection of
mice with the most recent 2009 pandemic H1N1 IAV resulted
in much-stronger lung immune responses and weight loss than
infection with recent seasonal H1N1 and H3N2 IAVs (Figures
1A and 1B). The HA protein of this pandemic IAV is characterized
by poor glycosylation of the globular head, as are all known
pandemic strains. After previous introductions of pandemic
IAVs including the 1918 H1N1 and 1968 H3N2 strains into hu-
mans, these IAV viruses subsequently acquired additional glyco-
sylation sites on the HA globular head during adaptation to
humans (Vigerust et al., 2007). To understand the impact of these
glycosylation changes on IAV pathogenicity and adaptation to
humans, we utilized viruses carrying either 1968 pandemic
(HK; poorly glycosylated) or 1999 seasonal (Pan; heavily glyco-
sylated) H3N2 HA/NA proteins in various combinations. These
‘‘6:2’’ IAVs created by the eight-plasmid reverse genetics system
carry the six internal gene segments from the IAV laboratory1592 Cell Reports 11, 1591–1603, June 16, 2015 ª2015 The Authorsstrain PR8 and the appropriate gene segments to express the
pandemic (HK) or seasonal (Pan) surface proteins. Inflammatory
responses and pathology could be clearly linked to pandemicHA
expression (Figures 1C and 1D). To avoid potential confounding
caused by differences in virus accumulation of the different 6:2
viruses (Figure S1), we next testedwhether we could seasonalize
a pandemic IAV by addition of the corresponding glycosylation
sites. Isogenic viruses representing the 1968 pandemic H3N2
IAV (WT) and two viruses carrying two (+II) or four (+IV) additional
glycosylation sites on the globular head of HA were constructed
as described (Vigerust et al., 2007). The stepwise addition of gly-
cans to the HA in the absence of other changes resulted in corre-
spondingly reduced airway inflammation and pathology upon
infection with the different IAV (Figures 1E and 1F). Further ana-
lyses demonstrated reduced morbidity on the level of body
weight loss (Figures 1G and 1H) and mortality (Figure 1I) associ-
ated with increased glycosylation. Infection of a second mouse
line revealed comparable results (Figures S2A and S2B), broad-
ening the phenotype. Finally, the addition of at least two addi-
tional glycans to the pandemic HA protein was not associated
with reduced viral growth (Figure 1J), excluding a virus propaga-
tion disadvantage as the primary mechanism of reduced patho-
genicity in these experiments. The addition of further two glycans
(+IV virus) did result in attenuated growth (Figure 1J), likely due to
collectin neutralization (Reading et al., 2007; Vigerust et al.,
2007), which led us to exclude this virus from later molecular
mechanistic studies so as not to confound the results.
Poor Glycosylation Is Associated with Inflammation and
Pathology
After the initial finding of increased pro-inflammatory cytokine
expression in lungs infected with viruses expressing HAs from
pandemic IAVs, we assessed the impact of HA glycosylation
on airway inflammation. Investigations of responses to isogenic
IAVs only differing in the amount of glycosylation sites on the HA
demonstrated a dampening of inflammation with the stepwise
addition of glycans. Assessment of pro-inflammatory cytokine/
chemokine expression on the mRNA level (Figure 2A) as well
as the protein level (Figure 2B) revealed a strong inflammatory
response upon WT virus infection but stepwise reduced inflam-
mation upon infectionwith the +II and +IV virus variants. Infection
with the WT virus also resulted in infiltration of immune cells into
airways compared to lower cell counts upon +II and +IV virus
infection (Figure 2C). An analysis of specific cell types demon-
strated that depletion of resident airwaymacrophages, as shown
earlier by our group (Ghoneim et al., 2013), and accumulation of
inflammatory cells, including exudative macrophages and neu-
trophils, was strongest upon WT infection with a lesser or no
impact during +II and +IV virus infections (Figure 2C). Analysis
of the ratio of resident macrophages, exudative macrophages,
and neutrophils in BALF showed an almost complete shift from
resident macrophages in naive mice to infiltrating inflammatory
cells in WT virus infection, a shift seen to lesser extent in +II
and only to a marginal extent in +IV virus infections (Figure 2D).
Taken together, these data clearly demonstrate an impact of
HA glycosylation on airway inflammation. Alongwith these differ-
ences, we detected an HA glycosylation-dependent increase in
lung pathology using pathology markers such as total BALF
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Figure 1. Lack of HA Globular Head Glyco-
sylation Triggers Lung Inflammation and
Pathogenicity
Groups of (A and B) ten and (C–J) five BALB/c mice
were infected intranasally (A and B) with 104 PFU of
pandemic (p) 2009 H1N1 HH04, seasonal (s) H3N2
Pan/99, or seasonal (s) H1N1 Mem/01, (C and D)
with 104 PFU of viruses carrying different combi-
nations of pandemic (HK) and seasonal (Pan) HA/
NA surface proteins on a six-gene-segment PR8
backbone (HK/HK 6:2, Pan/Pan 6:2, HK/Pan 6:2,
and Pan/HK 6:2) and (E–J) with (E, F, G, and J) 53
105 and (H and I) 106 PFU of isogenic viruses
differing in the number of N-linked glycosylation
sites on the HA globular head (HK WT, HK +II, and
HK +IV). (A–F) PBS-inoculated mice served as
control. (A, C, and E) Lung mRNA levels of Il6 and
Ccl2 3 days post infection are depicted as the fold
change of levels of the PBS-inoculated mice, and
(B, D, and F) body weight (%; compared to starting
weight) is shown. (G and H) Body weight changes
over 15 days are depicted, and (I) Kaplan-Meier
survival curve analysis was performed. (J) Virus
lung titers on d2, d3, d5, and d7 post-infection are
depicted as PFU/ml. (A–H) Data are represented as
mean with SD, (J) each dot represents an individual
mouse, and bars show mean. An asterisk (*) in-
dicates statistically significant differences (p <
0.05) between (A and B) HH04 pH1N1 and all other
groups, (C and D) HK/HK 6:2 and HK/PAN 6:2 and
all other groups, (E–I) HK WT and all other groups,
and (J) HK +II and HK +IV to HK WT. See also
Figures S1 and S2.protein (Figure S3A), BALF LDH levels (Figure S3B), and lung
edema (Figures S3C and S3D). Histology analyses confirmed
gross differences in lung pathology upon WT, +II, and +IV virus
infection (Figure S3E), with marked denudation of bronchioles
following only the WT virus infection (Figure S3F). Finally, ana-
lyses of markers of lung physiology revealed adverse effects
on lung homeostasis and functionality characterized by generally
increased airway resistance and decreased lung compliance
upon infection with the WT virus, findings that were reducedCell Reports 11, 1591–160upon infection with the higher glycosy-
lated IAV viruses (Figure S4) and are
consistent with the observation of
decreased inflammatory responses and
decreased lung injury. Although the find-
ings of diminished pathogenicity for
the +IV virus may be partially due to differ-
ences in viral titer, alternate mechanisms
must be responsible for the differences
in WT and +II viruses because these
variants to not differ in replication or viral
lung load.
Global Impact of HA Glycosylation
on the Lung Transcriptome
In order to understand the mechanisms
underlying the association between HAglycosylation and inflammation upon IAV infections, we as-
sessed the whole lung transcriptome. Microarray analysis re-
vealed clear differences between the experimental groups. The
WT-virus-infected lungs displayed a different gene expression
profile by principal-component analysis (PCA) compared to
lungs from naive mice and from +II- and +IV-virus-infected
mice (Figure 3A). The expression profile of +II-virus-infected
lungs was closer to but remained distinct from the WT-virus-
infected lungs, whereas the gene expression profile of3, June 16, 2015 ª2015 The Authors 1593
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Figure 2. Addition of Glycosylation Sites to the Pandemic HA Abolishes Lung Inflammation upon IAV Infection
Five (A, C, and D) and four to five (B) BALB/c mice per group were infected with 5 3 105 PFU of isogenic viruses carrying differentially glycosylated HA globular
heads (HKWT, HK +II, and HK +IV). PBS-inoculatedmice served as control. (A) Total lungmRNA levels of Ifnb1, Il6,Ccl2, Tnf, andCxcl1 2 days post-infection are
shown as n-fold of the PBS-inoculated mice, and (B) total lung protein levels for IL6, CCL2, and TNF in pg/ml 3 and 5 days after infection are depicted. (C and D)
Five days after infection, BALF was collected and cellular composition was analyzed. (C) Total cell counts and counts for specific cell types (resident macro-
phages, exudativemacrophages, and neutrophils) are depicted as cells in BALF/mouse. (D) Relative proportions of cell typeswithin the BALF cell composition are
shown as parts of whole. (A–C) Data are represented as mean with SD, and (D) mean values for each experimental group were used. An asterisk (*) indicates
statistically significant differences (p < 0.05) between HK WT and all other groups. In (C) resident macrophages, an asterisk (*) indicates statistically significant
differences (p < 0.05) between HK WT and PBS and +IV. See also Figures S3 and S4.the +IV-infected lungs was comparable to but distinct from naive
mouse lungs (Figure 3A). Heatmap analyses revealed a candi-
date group of genes that were upregulated in WT-virus-infected
lungs compared to naive mice with a lesser extent of upregula-
tion in +II and an even weaker signal in +IV-virus-infected lungs
(Figure 3B). Focusing on this group of more than 1,000 genes
with the strongest associations with glycosylation demonstrated
that they were enriched in genes involved in inflammatory re-
sponses (Figure 3C). Of interest, genes linked to ER stress and1594 Cell Reports 11, 1591–1603, June 16, 2015 ª2015 The Authorsthe UPR were highly correlated with glycosylation status,
prompting further investigation (Figure 3D).
ER Stress Mediates Inflammatory Responses to Viral
Infections
To further probe the molecular mechanism of increased inflam-
mation upon pandemic IAV infections, we next assessed the po-
tential involvement of ER stress and the UPR. Isolating the infec-
tion process to lung epithelial cells, which are the main cell type
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Figure 3. Global Lung Transcriptome upon
IAV Infection Is Altered due to HA Globular
Head Glycosylation
Five BALB/c mice per group were infected intra-
nasally with 5 3 105 PFU of isogenic viruses car-
rying differentially glycosylated HA globular heads
(HKWT, HK +II, and HK +IV). PBS-inoculated mice
served as controls. Two days after infection, total
lung RNA was used for analysis of the global lung
transcriptome.
(A) Principal-component analysis (PCA) visualiza-
tion of IAV-infected and PBS control mice is de-
picted. This visualization captures 40.3% of the
variability across samples in the top three com-
ponents.
(B) The Z transformed complete data set shows
color-coded expression (heatmap) clustered by
gene and displayed by experimental class.
(C) Data from a select group (bar indication in B) of
genes showing the highest upregulation in HK WT
infection was tested for GO enrichment using
DAVID. Redundant categories were removed, and
the p value of enrichment waslog10 transformed
to create a score for visualization in the bar chart.
(D) A select group of HK WT-induced genes (ER
stress genes) are visualized in this heatmap.productively infected by IAV, and only focusing on viruses having
comparable growth characteristics (WT and +II virus) to avoid
confounding, profound differences in the inflammatory response
were evident upon infection (Figure 4A). Infection with the WT vi-
rus resulted in higher induction of IFNB1, IL6, and CCL2 mRNA
compared to +II virus infection. This result was not affected by
reduced accumulation of viral material, a concern that could
confound the data, because the +II virus replicated comparably
to the WT virus in this system (Figures 4B and S5A) and showed
generally comparable to slightly better growth in relevant cell
lines (Figures S5B and S5C). Expanding the number of genes
investigated, a qPCR-based analysis revealed strong upregula-
tion of multiple inflammatory genes in WT virus compared to +II-
virus-infected lung epithelial cells (Figure 4C). Additional experi-
ments in primary normal human bronchial epithelial cells
(NHBEs) confirmed the finding of more-pronounced inflamma-
tory responses upon WT virus infection in a second relevant hu-
man cell model (Figure 4D) in the absence of differences in repli-
cation (Figure 4E). We next assessed the contribution of different
ER stress pathways to the inflammatory response upon inflam-
mation and the involvement in altered immune reactions upon
infection with IAV in the setting of differentially glycosylated
HA proteins. Analyzing IRE1a phosphorylation, we demon-
strated activation in WT-virus-infected cells (Figure 4F) with
lesser activation in +II-virus-infected cells; this was consistent
with subsequent induction of the mitogen-activated protein
(MAP) kinase JNK pathway (Figure 4F), which has been linked
to ER stress (Darling and Cook, 2014) and is involved in inflam-
matory responses to IAV infection (Ehrhardt et al., 2010). Exam-
ining the activation of PERK and ATF6 as additional pathways
triggered upon ER stress, we could illustrate PERK phosphoryla-
tion in WT compared to +II infections and found that this wasCevirus MOI dependent (Figure 4G). ATF6 activation cleavage
was if any minimal, arguing that the contribution of ATF6 in
IAV-induced, ER-stress-mediated inflammation seems to be
minimal or none (Figure 4G). Analyzing expression of several
UPR-dependent genes revealed at most weak upregulation of
some genes upon WT infection without a general pattern of in-
duction (Figure 4H) at the point in time of strong induction of
inflammatory responses (Figure 4I). These data do not exclude
a specific contribution of particular UPR genes but do suggest
that activation of the ER stress kinases IRE1a and PERK and
subsequent initiation of inflammatory pathways is potentially
the more critical event. Probing the hypothesis through use
of the regulatory compound phenylbutyric acid (PBA) to inhibit
ER stress, we could illustrate the interplay of this pathway
with induction of inflammatory responses upon infection with
pandemic IAV (Figure 5A). Activation of the MAP kinase JNK
and p38 pathways was stronger upon WT virus infection
compared to +II virus infection, and inhibition of ER stress re-
sulted in a reduction of WT-virus-induced activation of these
pathways along with diminished IRE1a activation (Figure 5A).
Cytokine/chemokine analyses of inflammatory responses upon
pandemic IAV infection supported this interpretation with
decreased induction of inflammatory genes after inhibition (Fig-
ure 5B), data confirmed with a second molecular chaperone
(TUDCA) also decreasing ER stress (Figure 5C). To broaden
the relevance of the explicated mechanism of ER stress induc-
tion on inflammatory responses related to glycosylation status,
we utilized different respiratory syncytial viruses (RSVs) propa-
gated either in HEp2 or Vero cells, because the major glycosy-
lated surface protein of RSV is truncated when propagated in
Vero cells, resulting in a significant loss of glycosylation (Dersc-
heid et al., 2013; Kwilas et al., 2009; Rixon et al., 2002). Analyzingll Reports 11, 1591–1603, June 16, 2015 ª2015 The Authors 1595
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the inflammatory response upon infection with these two ver-
sions of RSV revealed differences in expression of pro-inflamma-
tory cytokines and differential induction of DDIT3 expression
(Figure 5D) along with comparable virus growth (Figure S5D),
showing that the glycosylation status of the RSV surface protein
also affects the induction of cellular immune responses.
ER Stress Is Responsible for the Pathogenicity of
Pandemic IAV
Having clearly established the link between HA glycosylation, ER
stress activation, and inflammatory responses in epithelial cells
and the lungs, we next sought to demonstrate that these over-
exuberant inflammatory responses are the basis for pandemic
IAV pathogenicity. Therefore, we manipulated the inflammatory
response using several approaches and analyzed the outcome
on IAV pathogenesis. First, artificially stimulating inflammatory
responses using exogenous lipoteichoic acid (LTA) in +II-virus-
infected lungs resulted in elevated pathogenicity to the level of
WT virus infection (Figure 6A), showing that the dampened
inflammation upon +II virus infection is the basis for reduced
morbidity and mortality in the model. In addition, reduction of in-
flammatory responses upon WT virus infection rescued infected
animals, either using CCL2-deficient mice (Figure 6B), which
have alterations in inflammatory responses such as less infiltra-
tion of inflammatory cells (Conrady et al., 2013; Dessing et al.,
2007; Frangogiannis et al., 2007; van Zoelen et al., 2011), or us-
ing imatinib (Figure 6C) as a broadly active anti-inflammatory
drug (Wolf et al., 2005). Both approaches helped WT-infected
animals to survive, whereas the control animals died (Figures
6B and 6C). In further support of the concept of ER stress as
the source of this pathological inflammation, treatment of mice
with a chemical chaperone that decreases ER stress by promot-
ing protein folding rescued WT-infected animals (Figure 6D). To
confirm our key findingswith a second, recent pandemic IAV, the
2009 H1N1pdm virus utilized in the initial comparisons to sea-
sonal strains (Figures 1A and 1B), we constructed an otherwise
isogenic +II version and repeated select experiments. Reduced
immune responses upon ER stress inhibition were seen in a
comparison of untreatedWT virus to treatment with PBA (Figures
7A and 7B). Addition of two glycans to the globular head of the
HA resulted in reduced inflammatory responses in line with
reduced ER stress induction on the level of Ddit3mRNA expres-
sion (Figure 7C), as well as decreased morbidity and mortality
(Figures 7D and 7E). Taken together, our data illuminate the inter-
play of poorly glycosylated HA proteins, zoonotically introduced
into humans during pandemic outbreaks, with induction ofFigure 4. ER-Stress-Mediated Sensing of Pandemic HA as Mechanism
A549 lung epithelial cells (A–C and F–I) or primary NHBE cells (D and E) were infec
(HKWT andHK +II) or (A, D, and F–I) mock infected. TheMOI usedwas (A, B, F, an
IFNB1, (A, D, and I) IL6, and (A and I) CCL2 are shown as n-fold of the mock infect
depicted in PFU/ml. (H) Cellular mRNA level of the depicted ER stress genes 12 h
Profiler)-based analysis of inflammatory gene expression of HKWT- and HK +II-in
inflammatory genes after HK WT infection compared to HK +II infection and (C, lo
depicted. (F andG) Cells were harvested 12 hr after infection for western blot analy
D, E, H, and I) Data are represented as mean with SD. (A, B, D, E, and I) Represent
samples are shown. (F and G) Representative blots of three independent experime
consisting of three biological samples, are shown. (C) cDNA of three different biol
significant differences (p < 0.05) between HK WT and all other groups. See also
Ceinflammation through an ER stress pathway, resulting in pathol-
ogy. It can be speculated that these pandemic viruses adapted
to the human host by selection of variants with increased glyco-
sylation because avoidance of ER-stress-mediated immune
recognition and the resulting massive airway inflammation and
pathology benefitted the virus.
DISCUSSION
The versatile interplay of invading pathogens and host immune
responses is critical for determining both the severity and the
outcome of infections. Pathogen-host co-evolution has resulted
in manifold receptors for sensing pathogens (Mulhern et al.,
2009). Although recognition of viral RNA by sensors such as
RIG-I is thought to be one of the most important mechanisms
of sensing, IAVs have developed countermeasures for these sys-
tems and the complexity of the interactions suggests that other
pathways must be operable. In our current study, we addressed
the crucial involvement of ER stress pathways such as the UPR
in inflammatory responses and pathogenicity upon viral infec-
tions including both IAV and RSV. Innate sensing occurred at
the level of protein processing, recognizing the nascent HA pro-
teins from pandemic strains as ‘‘non-self’’ as a result of poor sur-
face glycosylation. Almost all identified innate sensors of viruses
rely on recognition of differences in nucleic acid composition to
trigger immune responses. Interestingly, the pathology in this
model stemmed from these immune responses, not direct dam-
age from the virus(es). We propose that this pathway operates
as an intracellular innate sensor, distinguishing ‘‘self’’ from
non-self by recognizing differentially glycosylated proteins as
foreign and triggering immune responses. In support of our
data, evidence for a regulatory involvement of ER stress inmicro-
bial infections was recently shown (Muralidharan and Mandre-
kar, 2013) and an interplay of ER stress and viral infections
was suggested for human pathogens such as HBV (Liu et al.,
2013), HCV (Chan, 2014), and influenza virus (Hassan et al.,
2012; Roberson et al., 2012). More recently, a potential direct
contribution of ER stress to recognition of viral infections was
speculated upon (Smith, 2014). Finally, a general contribution
of ER stress to lung inflammation as well as acute lung injury in
human patients was recently described (Kim et al., 2013).
Here, we link these observations and provide the mechanism
that ties them together—proteins that are differentially glycosy-
lated relative to other, perhaps more ‘‘natural’’ proteins trigger
ER stress, and the activation of signaling events downstream
of the UPR results in inflammation and pathology.of Immune Recognition
ted with isogenic viruses carrying differentially glycosylated HA globular heads
d G)MOI = 5 and (C–I) MOI = 10. (A, D, and I) Cellular mRNA levels of (A, D, and I)
ed cells (A and D) 24 hr and (I) 12 hr after infection, and (B and E) virus titers are
r after infection are shown as n-fold of the mock infected cells. (C) qPCR (RT2
fected cells is shown. (C, upper panel) Heatmap visualization of fold increase of
wer panel) list of genes upregulated in HK WT compared to HK +II infection are
sis. Detection of the indicated proteins was donewith specific antibodies. (A, B,
ative data of three independent experiments each consisting of three biological
nts are shown and (H) mean values from three independent experiments, each
ogical samples were pooled and analyzed. An asterisk (*) indicates statistically
Figure S5.
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Figure 5. ER Stress as a Central Regulator for Inflammatory Responses upon Viral Infections
A549 lung epithelial cells were infected with (A–C) isogenic IAV carrying differentially glycosylated HA globular heads (HK WT and HK +II; MOI = 10) and (D) two
RSV A2 virus variants differing in surface protein glycosylation (RSV HEp2 and RSV Vero; MOI = 5). Mock infected cells served as control. After infection, cells
were treated with (A and B) 10 mM PBA or (C) 500 mg/ml TUDCA. (A) Cells were harvested 12 hr after infection for western blot analysis, and indicated proteins
were detected with specific antibodies. (B–D) Cellular mRNA levels of (B–D) IFNB1, IL6, CCL2, and (D) DDIT3 are shown as n-fold of the mock-infected cells (B
and C) 12 hr and (D) 24 hr after infection. (B–D) Data are represented as mean with SD. (A) Representative blots of three independent experiments; (B and C)
representative data of three independent experiments, each consisting of three biological samples; and (D) representative data of two independent experiments,
each consisting of four biological samples, are shown. An asterisk (*) indicates statistically significant differences (p < 0.05) between (B and C) HKWT and all other
groups and (D) RSV HEp2 to all other groups. See also Figure S5.
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Figure 6. ER-Stress-Mediated Inflammation
Triggers Pandemic IAV Pathogenicity
(A) Five BALB/c mice per group were intranasally
infected with 106 PFU of isogenic viruses carrying
differentially glycosylated HA globular heads (HK
WT and HK +II) or PBS for control. At d2 post-
infection, different groups were either treated with
100 mg LTA or PBS intranasally. (B) Ten C57BL/6
WT and eleven Ccl2/ mice per group were in-
fected intranasally with 105 PFU HK WT virus. (C
and D) Five BALB/c mice per group were infected
intranasally with 106 PFU HK WT virus. (C) Animals
were treated i.p. with 25 or 50 mg/kg/day imatinib
and (D) 200 mg/kg/day PBA or solvent control.
Survival was monitored for 15 days, and Kaplan-
Meier survival curve analysis was performed. An
asterisk (*) indicates statistically significant differ-
ences (p < 0.05) between (A) HK +II PBS d2 and
HK +II LTA d2 treated mice, (B) C57BL/6 WT and
Ccl2/ mice, and (C and D) between HK WT-
infected mice and all treatment groups.The natural host niche of IAV is the gut of wild birds and water-
fowl. All previous pandemic viruses, having left this environment
and crossed species barriers to establish endemic infections in
the respiratory tract of humans, have been poorly glycosylated.
Such viruses would be predicted to be recognized through
this mechanism, promoting virulence and morbidity. Indeed,
pandemic viruses including the 2009 H1N1 strain are typically
more virulent than related seasonal strains (Reed et al., 2014).
Virulence of the 1918 pandemic strain has been linked clearly
to the HA and to its glycosylation status, adding further support
for the importance of this mechanism (Sun et al., 2013; Tumpey
et al., 2004). Over decades of circulation, negative selection for
this trait that allows immune recognition would favor accumula-
tion of glycans on the HA surface to avoid triggering ER stress, a
pattern that has been recapitulated in nature with both the H1N1
and H3N2 lineages. Glycosylation variants of the 2009 H1N1
pandemic strain are already being detected in nature, suggest-
ing that adaptation to avoid this sensing is already taking place
(Mullick et al., 2011) and emphasizing the need to evaluate the
consequences on IAV pathogenicity for different virus isolates
(Medina et al., 2013; Zhang et al., 2013). More broadly, it is likely
that this ability to discriminate non-self at the level of protein
folding and processing has utility in maintaining cellular homeo-
stasis in the face of viral invasion and provides an alternative to
nucleic-acid-based innate sensors, which can be circumvented
by a variety of strategies. However, our data demonstrate that
this may also have untoward consequences, because pathology
can result from the unrestrained inflammation. As societal and
climate change drive further emergence of pathogens new to
humans from animal reservoirs, a deeper understanding of vi-
rus-host interactions at a molecular level is needed to prevent
or mitigate disease.
EXPERIMENTAL PROCEDURES
Cells, Viruses, Chemicals, and Infection Conditions
Madin-Darby canine kidney (MDCK) cells were cultured in MEM, whereas
the human lung epithelial cell line (A549) and the human embryonic kidney
cells (HEK293T) were cultivated in DMEM. NHBEs (Lonza) were culturedCeaccording to the manufacturer’s protocol using BEGM bullet kit (Lonza).
After refreezing and counting upon initial cell expansion, single vials were
thawed and directly seeded for experiments. Cell culture media were sup-
plemented with 10% heat-inactivated fetal bovine serum. The seasonal
IAV isolates A/Memphis/7/2001 (H1N1; Mem/01) and A/Panama/2007/1999
(H3N2; Pan/99) were taken from the strain collection at the St. Jude Chil-
dren’s Research Hospital. All recombinant IAVs were created as described
earlier (Vigerust et al., 2007). The 2009 pandemic IAV A/Hamburg/04/2009
(H1N1; HH04) and the isogenic mutant virus A/Hamburg/04/2009 HA +II
were rescued from the reverse genetics plasmid system kindly provided
by Dr. Thorsten Wolff (Robert Koch Institute). Two additional glycosylation
sites found in seasonal H1N1 IAV before 2009 were introduced into the
2009 pandemic HA to create the A/Hamburg/04/2009 HA +II virus
(142NHT and 177NLS; HH04 HA +II) for comparison to HH04 WT (142NHE
and 177KLS). Of note, the reverse genetic plasmid for A/Hamburg/04/2009
HA (protein accession number ACR10223.1) carries the mutation D144E.
The different viruses consisting of six internal gene segments of A/Puerto
Rico/8/34 (H1N1) and different combinations of seasonal (A/Panama/2007/
99 H3N2; Pan) and pandemic (A/Hong Kong/1/68 H3N2; HK) HA and NA
segments (referred to as 6:2 viruses) were created as described earlier
(Vigerust et al., 2007) as were the isogenic viruses consisting of PR8 internal
genes and A/Hong Kong/1/68 H3N2 (HK) HA and NA segments either wild-
type HA (HK WT) or carrying two (HK +II) or four additional (HK +IV) glyco-
sylation sites (Vigerust et al., 2007). The presence of the desired mutation(s)
in each virus was confirmed by sequencing. All viruses were grown on
MDCK cells. The infection procedure of cells was conducted as described
earlier (Hrincius et al., 2010). The human RSVs A2 for alteration in glycosyl-
ation studies were grown either in Vero cells or HEp2 cells for alteration in
surface proteins as described earlier (Kwilas et al., 2009). The chemical
chaperones PBA (Sigma-Aldrich; sodium salt) and TUDCA (Sigma-Aldrich;
sodium salt), the chemical inhibitor imatinib mesylate (STI571; Selleckchem),
and the bacterial cell wall polymer LTA (InvivoGen) were dissolved in water
and used as indicated.
Standard Plaque Titration
Analysis of the number of infectious particles (plaque titers) was conducted by
collecting samples (tissue culture supernatants and lung homogenates) at the
indicated points in time post-infection (p.i.) and assessed in standard plaque
titration as described earlier in Hrincius et al. (2010).
Mouse Infections
All mouse studies were performed in compliance with animal welfare regula-
tions under an animal protocol approved by the Animal Care and Use Commit-
tee of St. Jude Children’s Research Hospital. Seven to eight-week-old femalell Reports 11, 1591–1603, June 16, 2015 ª2015 The Authors 1599
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Figure 7. Addition of Glycosylation Sites to the 2009 Pandemic Virus HA Abrogates Lung Inflammation and Pathogenicity
(A and B) A549 lung epithelial cells were infected with the pandemic 2009 H1N1 (HH04) virus (MOI = 5) and treated with 10 mM PBA or left untreated. Mock
infected cells served as control, and cells were harvested 12 hr after infection. (A) Western blot analysis was conducted, and detection of the indicated proteins
was done with specific antibodies. (B) IL6 mRNA level is shown as n-fold of the mock infected cells.
(C–E) Five BALB/cmice per groupwere infected intranasally with (C) 103 PFU or (D and E) 104 of isogenic viruses carrying different glycosylated HA globular heads
(HH04 andHH04HA +II), (C) with PBS-infected animals serving as control. (C) Total lungmRNA levels of Ifnb1, Il6,Ccl2, andDdit3 3 days after infection are shown
as n-fold of the PBS-inoculated mice. (D) Body weight changes over the course of infection (15 days) are depicted, and (E) Kaplan-Meier survival curve analysis
was performed. (B–D) Data are represented as mean with SD. (A) Representative blots of three independent experiments and (B) representative data of three
independent experiments, each consisting of three biological samples, are shown. An asterisk (*) indicates statistically significant differences (p < 0.05) between
HH04 and the other groups and (C) between HH04 and PBS for Ddit3 mRNA.BALB/c mice or C57BL/6 WT and Ccl2/ (B6.129S4-Ccl2tm1Rol/Jmice; Jack-
son Laboratory) were used for the mouse studies. The animals were lightly
anesthetized with 2.5% inhaled isoflurane (Baxter) and afterward infected
intranasally with the indicated viruses and plaque-forming units (PFU) in a final
volume of 50 ml. Mice weremonitored daily for weight loss, disease symptoms,
and mortality. In accordance with protection of animal welfare restrictions,
mice were sacrificed after weight loss of 30% and considered to have died
that specific day.1600 Cell Reports 11, 1591–1603, June 16, 2015 ª2015 The AuthorsViral Lung Titers and Cytokine/Chemokine Protein Analysis
For determination of virus titers and cytokine/chemokine protein levels, mouse
lungs were collected in PBS, homogenized using a FastPrep-24 homogenizer
with Lysing Matrix D (both from MP Biomedical), and adjusted with PBS to
obtain a 10% tissue homogenate. The samples were cleared of debris, and su-
pernatants were used for virus titer determination in standard plaque titration
and formeasuring the concentration of interleukin 6 (IL6), tumor necrosis factor
(TNF), and chemokine (C-C motif) ligand 2 (CCL2) using a custom multiplex
cytokine/chemokine assay (Millipore) analyzed with a Luminex xPOTENT 3.1
system (Bio-Rad) following manufacturer’s protocol.
Total RNA Isolation and Quantitative Real-Time PCR
Total RNA from cells was isolated using the RNeasy Mini Kit (QIAGEN) accord-
ing to the manufacturer’s protocol. For analysis of cytokine/chemokine levels,
mouse lungswere collected in Trizol andRNAwas isolated using Trizol method
(Chomczynski and Sacchi, 1987) and PureLink RNA Mini Kit (Ambion). For
reverse transcription of mRNA, 1 or 2 mg total RNA and 0.5 mg oligo(dT) primer
were used. The reverse transcription was done using M-MLV Reverse
Transcriptase (Promega) according to the manufacturer’s protocol. For
qPCR reaction, QuantiTect SYBR Green PCR Kit (QIAGEN) was used accord-
ing to manufacturer’s recommendation. Relative mRNA concentrations were
determined after 40 cycles of amplification with Applied Biosystems 7300
Rea-Time PCR System by using the 2DDCT method (Livak and Schmittgen,
2001). The housekeeping gene GAPDH served as internal standard. The
following primers were used: QuantiTect primer (QIAGEN); Mm_Gapdh_3_SG;
Mm_Il6_1_SG; Mm_Ccl2_1_SG; Mm_Ifnb1_1_SG; Mm_Tnf_1_SG; Mm_
Cxcl1_1_SG; Mm_Ddit3_1_SG; HS_GAPDH_2_SG; HS_IFNB1_1_SG; HS_
IL6_1_SG; HS_CCL2_1_SG; HS_DNAJB9_1_SG; HS_ATF4_1_SG; HS_ATF6_
1_SG; HS_TRA1_1_SG (HSP90B1); and primer for human DDIT3: fwd:
50AGAACCAGGAAACGGAAACAGA and rev: 50TCTCCTTCATGCGCTGCTTT,
human HSPA5: fwd: 50TGTTCAACCAATTATCAGCAAACTC and rev: 50TTCTG
CTGTATCCTCTTCACCAGT, human EDEM1: fwd: 50CAAGTGTGGGTACGC
CACG and rev: 50AAAGAAGCTCTCCATCCGGTC, human total XBP1
(tXBP1): fwd: 50TGGCCGGGTCTGCTGAGTCCG and rev: 50ATCCATGGG
GAGATGTTCTGG, and human spliced XBP1 (sXBP1): fwd: 50CTGAGTC
CGAATCAGGTGCAG and rev: 50ATCCATGGGGAGATGTTCTGG. ER stress
genes primer sequences were taken from Oslowski and Urano (2011). For
quantification of influenza M1 mRNA, fwd: CTTCTAACCGAGGTCGAAACGTA
and rev: GGATTGGTCTTGTCTTTAGCCA (Di Trani et al., 2006) primer were
used. For quantification of RSV NS1 gene, real-time RT-PCR was performed
as previously published (Boukhvalova et al., 2010). Total RNAwas reverse tran-
scribed to cDNA with NS1 antigenomic primer (50-CAATGAACTAGGATAT
CAAGAC-30) orwith oligo(dT) primers for the house-keeping geneHPRT1using
SuperScript III first-strand synthesis system (Life Technology). Real-time PCR
was performed with NS1 primers (50-CACAACAATGCCAGTGCTACAA-30 and
50-TTAGACCATTAGGTTGAGAGCAATGT-30 ) using Power SYBR Green PCR
MasterMix (Life Technology) on LightCycler 480 II (Roche). The relative amount
of RSV NS1 was normalized to HPRT1 (primers: 50-GGCTCCGTTATGGC
GACCCG-30 and 50-CGAGCAAGACGTTCAGTCCTGTCC-30 ) using 2DDCT
method.
The quantitative real-time PCR-based cytokine/chemokine analysis (RT2
Profiler PCR Array; human NFkB signaling targets [PAHS-225Z]; QIAGEN)
was conducted according to manufacturer’s protocol. Data analysis was con-
ductedbyRT2Profiler PCRArrayData Analysis software onQIAGENwebpage.
Western Blot Analysis and Antibodies
Western blot analysis was conducted as described earlier (Hrincius et al.,
2012). In brief, cells were lysed and cleared from debris, and Bradford method
was used for protein concentration measurement. Finally, cell lysates were
used for protein expression analysis using western blot technique. Activation
of ER stress was analyzed by phosphorylation of IRE1a (anti-IRE1a [pS724]
rabbit polyclonal antibody [pAb]; Novus Biologicals) and PERK (anti-PERK
[pT980] [16F8] rabbit monoclonal antibody [mAb]; Cell Signaling Technology)
and ATF6 cleavage (anti-ATF6 [70B1413.1] mouse mAb; Novus Biologicals).
Analysis of MAPK activation was conducted by analysis of JNK phosphoryla-
tion (anti-JNK [pThr183/pTyr185] [81E11] rabbit mAb; Cell Signaling Technol-
ogy) and p38 phosphorylation (anti-p38 [pThr180/pTyr182] [D3F9] rabbit mAb;
Cell Signaling Technology). Expression of influenza M1 and NS1 protein was
detected using a specific anti-M1 (GA2B) mouse mAb (Abcam) and specific
anti-NS1 (23-1) mouse mAb (developed at the IMV). Detection of JNK2 (anti-
JNK2 [56G8] rabbit mAb; Cell Signaling Technology), IRE1a (anti-IRE1a
[14C10] rabbit mAb; Cell Signaling Technology), PERK (anti-PERK mouse
pAb; ROCKLAND), and tubulin (anti-b-tubulin [9F3] rabbit mAb; Cell Signaling
Technology) was used for control. Protein bands were finally visualized using a
standard enhanced chemiluminescence (ECL) reaction.CeMicroarray
For microarray analysis of gene expression in mouse lungs, total lung RNAwas
isolated as described. RNA quality was confirmed by analysis on the Agilient
2100Bioanalyzer. Total RNA (100 ng) was processed in theHartwell Center mi-
croarray core according to the Affymetrix GeneChipWhole Transcript Labeling
protocol. 5.5 mg of biotinylated cDNA was fragmented and hybridized to
Affymetrix GeneChipMouse Gene 2.0 ST arrays and then stained and scanned
according to the manufacturer’s instructions. Data were RMA summarized (Iri-
zarry et al., 2003) and visualized by PCA. Next, each probe set was statistically
tested using ANOVA, and the resultant p values were adjusted for multiple
testing by the Bonferroni and Storey q value methods (Storey and Tibshirani,
2003) using Partek Genomics Suite 6.6. Hierarchical clustering and heatmap
visualization of Z score normalized data for complete data or select genes
were performed using Spotfire Decision Site. Gene Ontology (GO) enrichment
analysis was performed by the DAVID Bioinformatics Resources 6.7 software
developed and provided by the National Institute of Allergy and Infectious Dis-
eases (NIAID) (Huang et al., 2009). GO bar charts were scored and visualized
with STATA/MP 11.2.
BALF Collection, Flow Cytometry, and Pathologic Marker
For analysis of infiltration of inflammatory cells into mouse lungs and markers
of lung injury, BALF was collected at the indicated point in time as described
earlier (Hrincius et al., 2012). The harvested BALF cells were purified, counted,
and FACS analyzed as described previously (Hrincius et al., 2012). In brief,
FACS analyses were conducted to obtain counts for resident macrophages
(F4/80+, Gr1(low), CD11c(high), and MHC-II(low)), exudative macrophages (F4/
80+, Gr1(high), CD11c(int), and MHC-II(low)), and neutrophils (Gr1+, F4/80,
and CD11c). The remaining cell-free BALF was used to investigate markers
of lung injury. Total protein concentration measurement via the Bradford assay
(Bio-Rad) and LDH measurement via an LDH assay (Sigma-Aldrich) were
executed according to the manufacturer’s protocol.
Histopathology and Edema
For detailed pathological investigation of mice lungs, animals were euthanized
and lungs were fixed via intratracheal infusion followed by immersion in 10%
neutral buffered formalin solution. Afterward, tissues samples were embedded
in paraffin, automatically sectioned, and finally stained with H&E. A review was
conducted by a veterinary pathologist blinded to the purpose of the study and
to group composition to obtain gross pathology evaluation and pathology
scores. For lung edema investigation, total lungs were collected and wet
lung weight was determined as marker for inflammation and pathology in
lung. Afterward, lungs were dried at 70C for 48 hr and again weighed to obtain
dry lung weight. Finally, the wet-dry lung weight ratio was calculated asmarker
for lung edema.
Lung Physiology
For analysis of lung physiology upon influenza virus infections, animals were
anesthetizedwith 1mg/ml xylazine (Vedco) and 7mg/ml Euthasol (Virbac) prior
to surgical intubation and attachment to the flexiVent FX1 small animal venti-
lator (SCIREQ). Using the ‘‘mouse inhaled dose response’’ script, baseline
and responses to 25 mg/ml acetyl-b-methacholine (Sigma-Aldrich) were gath-
ered. Software-generated values for the respiratory system resistance (Rrs),
compliance (Crs), and elastance (Ers) and Newtonian resistance (Rn), tissue
damping (G), and tissue elastance (H) were recorded. The mean for each
was calculated for each animal prior to obtaining the mean and SD of the
mean for the group.
Statistical Analyses
Comparison of survival curves from groups of mice over a period of 15 days
was conducted using log rank (chi-square) test for statistical analysis of Ka-
plan-Meier survival data. ANOVA with Tukey test for multiple comparisons
was used for all multiple comparisons of data (cytokine/chemokine level, sin-
gle-day weight loss, in vivo viral titer, cell counts, lung pathology marker, pa-
thology scores, lung physiology data, etc.). Student’s t test (with Welch’s
correction for samples with unequal variance) was used for comparison of viral
titer and viral RNA in vitro, and Student’s t test analysis with correction
for multiple tests (Holm-Sidak method) and two-way ANOVA for repeatedll Reports 11, 1591–1603, June 16, 2015 ª2015 The Authors 1601
measurements with Tukey test for multiple comparisons was conducted for
weight loss data over a period of 15 days. A p value of <0.05 was considered
significant for these comparisons. Prism6 (GraphPad) software was used for
all statistical analyses.
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